LEXICON PHARMACEUTICALS, INC. Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LEXICON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LEXICON PHARMACEUTICALS, INC. for June 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.45 | 57,724 | 718,935 | 3,516,214 | 3.5 M to 3.5 M (+1.67 %) |
| Jun 29 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.54 | 125,114 | 1,568,442 | 3,458,490 | 3.3 M to 3.5 M (+3.75 %) |
| Jun 26 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.95 | 228,264 | 2,955,083 | 3,333,376 | 3.1 M to 3.3 M (+7.35 %) |
| Jun 26 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.36 | 25,461 | 340,090 | 3,105,112 | 3.1 M to 3.1 M (+0.83 %) |
| Jun 21 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.27 | 51,600 | 684,613 | 3,079,651 | 3 M to 3.1 M (+1.70 %) |
| Jun 21 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.28 | 12,391 | 164,613 | 3,028,051 | 3 M to 3 M (+0.41 %) |
| Jun 21 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.45 | 8,982 | 120,819 | 3,015,660 | 3 M to 3 M (+0.30 %) |
| Jun 18 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.06 | 36,584 | 477,937 | 3,006,678 | 3 M to 3 M (+1.23 %) |
| Jun 18 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.66 | 9,200 | 116,462 | 2,970,094 | 3 M to 3 M (+0.31 %) |
| Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.83 | 107,023 | 1,373,244 | 2,960,894 | 2.9 M to 3 M (+3.75 %) |
| Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.75 | 98,626 | 1,257,452 | 2,853,871 | 2.8 M to 2.9 M (+3.58 %) |
| Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.89 | 29,747 | 383,427 | 2,755,245 | 2.7 M to 2.8 M (+1.09 %) |
| Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 10.15 | 10,000 | 101,500 | 11,428 | |
| Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Sell | S | 12.91 | 10,000 | 129,076 | 25,643 | 35.6 K to 25.6 K (-28.06 %) |
| Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 10.15 | 10,000 | 101,500 | 35,643 | 25.6 K to 35.6 K (+39.00 %) |
| Jun 07 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.93 | 57,439 | 742,508 | 2,725,498 | 2.7 M to 2.7 M (+2.15 %) |
| Jun 07 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.58 | 95,079 | 1,196,370 | 2,668,059 | 2.6 M to 2.7 M (+3.70 %) |
| Jun 07 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.45 | 173,121 | 2,156,187 | 2,572,980 | 2.4 M to 2.6 M (+7.21 %) |
| Jun 04 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.24 | 121,803 | 1,490,576 | 2,399,859 | 2.3 M to 2.4 M (+5.35 %) |
| Jun 04 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.22 | 147,339 | 1,800,041 | 2,278,056 | 2.1 M to 2.3 M (+6.91 %) |
| Jun 04 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 11.62 | 147,339 | 1,712,050 | 2,130,717 | 2 M to 2.1 M (+7.43 %) |